<DOC>
	<DOCNO>NCT00863707</DOCNO>
	<brief_summary>This study intend assess safety tolerance regadenoson subject renal impairment .</brief_summary>
	<brief_title>A Study Safety Tolerance Regadenoson Subjects With Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<criteria>Subject Stage III Stage IV renal impairment base National Kidney Foundation ( NKF ) Kidney Disease Outcomes Quality Initiative ( K/DOQI ) glomerular filtration rate ( GFR ) classification Subject diagnosis Coronary Artery Disease ( CAD ) risk factor CAD determine current medical diagnosis least 2 follow condition : Type 2 diabetes , hypertension , hypercholesterolemia , current history cigarette smoking ( minimum 10 packyears exposure ) obesity ( Body Mass Index ( BMI ) &gt; 30 ) Subject must abstain smoke 3 hour prior 8 hour post study drug administration Subject must abstain intake food beverage contain methylated xanthine derivative ( i.e . caffeine , theobromine , methylxanthine ) within 12 hour prior study drug administration FollowUp visit , food may reduce effect regadenoson derivative ( i.e . caffeine , theobromine , methylxanthine ) within 12 hour prior study drug administration FollowUp visit , food may reduce effect regadenoson Subject history additional clinically significant illness , medical condition , laboratory abnormality within 2 week prior Screening Female subject pregnant , lactate childbearing potential refuse use medically acceptable form contraception FollowUp visit complete</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>regadenoson</keyword>
	<keyword>chronic kidney disease stage III</keyword>
	<keyword>chronic kidney disease stage IV</keyword>
	<keyword>renal impairment</keyword>
	<keyword>coronary artery disease</keyword>
</DOC>